Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement

O. Fix, B. Hameed, R. Fontana, R. Kwok, B. Mcguire, D. Mulligan, D. Pratt, M. Russo, M. Schilsky, E. Verna, R. Loomba, D. Cohen, J. Bezerra, K. Reddy, R. Chung

Hepatology, 2020

Coronavirus disease 2019 (COVID‐19), the illness caused by the SARS‐CoV‐2 virus, is rapidly spreading throughout the world. Hospitals and healthcare providers are preparing for the anticipated surge in critically ill patients, but few are wholly equipped to manage this new disease. The goals of this document are to provide data on what is currently known about COVID‐19, and how it may impact hepatologists and liver transplant providers and their patients. Our aim is to provide a template for the development of clinical recommendations and policies to mitigate the impact of the COVID‐19 pandemic on liver patients and healthcare providers.

Cited by 179 publications.

Field of study: Medicine

10.1002/hep.31281